Drug Profile
MVA BN WEV
Alternative Names: Equine encephalitis virus vaccine - Bavarian Nordic; MVA-BN-WEV; MVA-BN-W + E + VLatest Information Update: 03 Jul 2023
Price :
$50
*
At a glance
- Originator Bavarian Nordic
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I Eastern equine encephalomyelitis; Venezuelan equine encephalomyelitis; Western equine encephalitis virus infections
Most Recent Events
- 03 Jul 2023 MVA BN WEV is still in phase I trials for Eastern equine encephalomyelitis, Venezuelan equine encephalomyelitis and Western equine encephalitis virus infections in USA (Bavarian Nordic pipeline, July 2023)
- 23 Dec 2022 Bavarian Nordic plans to initiate a phase II trial in 2024
- 28 Nov 2022 No recent reports of development identified for phase-I development in Eastern-equine-encephalomyelitis(Prevention) in USA